ArticleScientific reports2026

AZD6738 overcomes acquired olaparib resistance in BRCA1 mutation triple-negative breast cancer through down-regulation of BRCA2 and RAD51.

Lei Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.